Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

SPRC

+ Watchlist+ Portfolio

SciSparc Ltd.

Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.33
52-Week Range
$0.23 – $29.88
Market Cap
$665.38K
P/E (TTM)
0.00
EPS (TTM)
248.24
Dividend Yield
0.00%
Advanced Metrics
Price/Book
0.04
PEG Ratio
—
Return on Equity
-164.49%
Return on Assets
-26.05%
Gross Margin
950.81%
Operating Margin
-725.18%
Profit Margin
0.00%
Current Ratio
0.87
Debt/Equity
0.24
Total Debt
$2.68M
Free Cash Flow
$-343.25K
Revenue Growth
-38.40%
Earnings Growth
—
Enterprise Value
$5.73M

Market Snapshot

About

SciSparc is a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system. The company leverages a proprietary CBD-based drug platform to develop treatments for conditions including Tourette syndrome, Alzheimer disease, and autism spectrum disorder.